Previous Article | Next Article 
Infection and Immunity, January 2006, p. 794-797, Vol. 74, No. 1
0019-9567/06/$08.00+0 doi:10.1128/IAI.74.1.794-797.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Correlation between Lethal Toxin-Neutralizing Antibody Titers and Protection from Intranasal Challenge with Bacillus anthracis Ames Strain Spores in Mice after Transcutaneous Immunization with Recombinant Anthrax Protective Antigen
Kristina K. Peachman,1
Mangala Rao,1
Carl R. Alving,1*
Robert Burge,2
Stephen H. Leppla,3
Venigalla B. Rao,4 and
Gary R. Matyas1
Department of Vaccine Production and Delivery, Division of Retrovirology, U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Rockville, Maryland 20850,1
Division of Biometrics, Walter Reed Army Institute of Research, Silver Spring, Maryland,2
National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland,3
The Catholic University of America, Washington, D.C.4
Received 20 May 2005/
Returned for modification 7 September 2005/
Accepted 24 October 2005
Transcutaneous immunization of mice with recombinant protective antigen (rPA) of Bacillus anthracis resulted in significantly higher lethal toxin-neutralizing antibody titers than did intramuscular injection of alum-adsorbed rPA. Immunized mice were partially protected against intranasal challenge with 235,000 (10 50% lethal doses) Ames strain B. anthracis spores. A highly significant correlation was observed between toxin-neutralizing antibody titer and survival after challenge. Future experiments with rabbits and nonhuman primates should confirm the significance of protection by this vaccine strategy.
* Corresponding author. Mailing address: Department of Vaccine Production and Delivery, Division of Retrovirology, U.S. Military HIV Research Program, Walter Reed Army Institute of Research, 1600 East Gude Drive, Rockville, MD 20850. Phone: (301) 251-5061. Fax: (301) 762-7460. E-mail:
calving{at}hivresearch.org.
Editor: A. D. O'Brien
Infection and Immunity, January 2006, p. 794-797, Vol. 74, No. 1
0019-9567/06/$08.00+0 doi:10.1128/IAI.74.1.794-797.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Cao, S., Guo, A., Liu, Z., Tan, Y., Wu, G., Zhang, C., Zhao, Y., Chen, H.
(2009). Investigation of New Dominant-Negative Inhibitors of Anthrax Protective Antigen Mutants for Use in Therapy and Vaccination. Infect. Immun.
77: 4679-4687
[Abstract]
[Full Text]
-
Omland, K. S., Brys, A., Lansky, D., Clement, K., Lynn, F., and the Participating Laboratories,
(2008). Interlaboratory Comparison of Results of an Anthrax Lethal Toxin Neutralization Assay for Assessment of Functional Antibodies in Multiple Species. CVI
15: 946-953
[Abstract]
[Full Text]
-
Staats, H. F., Alam, S. M., Scearce, R. M., Kirwan, S. M., Zhang, J. X., Gwinn, W. M., Haynes, B. F.
(2007). In Vitro and In Vivo Characterization of Anthrax Anti-Protective Antigen and Anti-Lethal Factor Monoclonal Antibodies after Passive Transfer in a Mouse Lethal Toxin Challenge Model To Define Correlates of Immunity. Infect. Immun.
75: 5443-5452
[Abstract]
[Full Text]
-
Ghose, C., Kalsy, A., Sheikh, A., Rollenhagen, J., John, M., Young, J., Rollins, S. M., Qadri, F., Calderwood, S. B., Kelly, C. P., Ryan, E. T.
(2007). Transcutaneous Immunization with Clostridium difficile Toxoid A Induces Systemic and Mucosal Immune Responses and Toxin A-Neutralizing Antibodies in Mice. Infect. Immun.
75: 2826-2832
[Abstract]
[Full Text]
-
Rollenhagen, J. E., Kalsy, A., Cerda, F., John, M., Harris, J. B., LaRocque, R. C., Qadri, F., Calderwood, S. B., Taylor, R. K., Ryan, E. T.
(2006). Transcutaneous Immunization with Toxin-Coregulated Pilin A Induces Protective Immunity against Vibrio cholerae O1 El Tor Challenge in Mice.. Infect. Immun.
74: 5834-5839
[Abstract]
[Full Text]